Report copyright - FY 2018 HIGHLIGHTS - Brandeis University · has a strong track record in the market, with 37 active licenses, including: • Two FDA-approved hemophilia therapeutics, Eloctate™
Please pass captcha verification before submit form
Please pass captcha verification before submit form